Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
January 14, 2019 Cover
Volume 97, Issue 2
Looking ahead to the biggest issues for chemistry worldwide, including geopolitical and economic drivers, market prospects, and environmental factors
Cover image:Cover of C&EN, January 14, 2019.
Credit: Will Ludwig/C&EN/Shutterstock
C&EN’s World Chemical Outlook 2019
Looking ahead to the biggest issues for chemistry worldwide, including geopolitical and economic drivers, market prospects, and environmental factors
What is the price of fire safety?
As lawsuits pile up and government pressure rises, firefighting-foam makers reconsider the environmental cost of fluorosurfactants
A blood test for Alzheimer’s disease draws near
New assays and biomarkers are bringing the decades-long quest to develop a blood test for Alzheimer’s disease closer to the finish line
-
Japan is a proving ground for the senior market
With the world’s grayest society, the country is becoming a preferred location to test new materials addressing the needs of the elderly
-
An engineering center at Rutgers fosters continuous tableting
A consortium’s members move forward on transforming oral dosage–form manufacturing
-
ADVERTISEMENT
Science Concentrates
Deals at J.P. Morgan health-care meeting signal busy M&A year
Lilly’s $8 billion purchase of Loxo Oncology is one of several announced at San Francisco event
